US Patent No: 8,114,437

Number of patents in Portfolio can not be more than 2000

Solvent/polymer solutions as suspension vehicles

1 Status Updates

Stats

ALSO PUBLISHED AS: 20060193918
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
INTARCIA THERAPEUTICS, INC.EMERYVILLE, CA73

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ayer, Rupal A Cupertino, CA 16 65
Chen, Guohua Sunnyvale, CA 67 609
DesJardin, Michael A - 52 243
Houston, Paul R Hayward, CA 30 165
Lam, Stan Dublin, CA 24 100
Luk, Andrew S Castro Valley, CA 14 36
Rohloff, Catherine M Los Altos, CA 27 105
Zamora, Pauline Sausalito, CA 13 35

Cited Art

Patent Info (Count) # Cites Year
 
INTARCIA THERAPEUTICS, INC. (32)
5,728,396 Sustained delivery of leuprolide using an implantable system 159 1997
5,985,305 Sustained delivery of an active agent using an implantable system 80 1997
6,132,420 Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems 43 1997
5,997,527 Self adjustable exit port 49 1998
6,113,938 Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents 47 1998
6,287,295 Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems 58 1998
6,524,305 Osmotic delivery system flow modulator apparatus and method 36 1998
6,375,978 Rate controlling membranes for controlled drug delivery devices 54 1998
6,270,787 Osmotic delivery system with membrane plug retention mechanism 46 1998
5,972,370 Peptide/protein suspending formulations 35 1999
6,156,331 Sustained delivery of an active agent using an implantable system 40 1999
6,261,584 Sustained delivery of an active agent using an implantable system 69 1999
6,217,906 Self adjustable exit port 17 1999
6,544,252 Osmotic delivery system having space efficient piston 31 1999
7,258,869 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle 25 2000
6,508,808 Valve for osmotic devices 32 2000
6,395,292 Sustained delivery of an active agent using an implantable system 53 2001
7,163,688 Osmotic implant with membrane and membrane retention means 25 2002
6,840,931 Osmotic delivery system flow modulator apparatus and method 17 2002
7,014,636 Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel 30 2002
2003/0108,609 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles 9 2002
7,074,423 Osmotic delivery system with early zero order push power engine 25 2003
6,939,556 Minimally compliant, volume efficient piston for osmotic drug delivery systems 32 2003
2004/0224,903 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device 38 2003
7,207,982 Osmotic pump with means for dissipating internal pressure 25 2004
2005/0112,188 Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle 27 2004
2005/0175,701 Capillary moderator for osmotic delivery system 25 2005
2005/0266,087 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium 34 2005
2006/0251,618 Implantable device for continuous delivery of interferon 13 2006
2006/0246,138 Polyoxaester suspending vehicles for use with implantable delivery systems 25 2006
2007/0281,024 Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator 25 2007
2009/0087,408 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device 5 2008
 
DURECT CORPORATION (17)
5,151,093 Osmotically driven syringe with programmable agent delivery 25 1990
5,312,389 Osmotically driven syringe with programmable agent delivery 49 1992
5,904,935 Peptide/protein suspending formulations 29 1995
5,932,547 Non-aqueous polar aprotic peptide formulations 38 1997
6,130,200 Gel composition and methods 59 1997
6,331,311 Injectable depot gel composition and method of preparing the composition 41 1997
6,124,261 Non-aqueous polar aprotic peptide formulations 35 1999
6,235,712 Non-aqueous polar aprotic peptide formulations 30 2000
6,673,767 Gel composition and methods 33 2000
6,468,961 Gel composition and methods 22 2000
2003/0180,364 Catheter injectable depot compositions and uses thereof 10 2002
2004/0024,069 Injectable depot compositions and uses thereof 11 2002
2004/0001,889 Short duration depot formulations 15 2003
2005/0008,661 Non-aqueous single phase vehicles and formulations utilizing such vehicles 37 2004
2005/0276,856 Non-aqueous single phase vehicles and formulations utilizing such vehicles 25 2005
2006/0216,242 Suspending vehicles and pharmaceutical suspensions for drug dosage forms 27 2006
2007/0027,105 Peroxide removal from drug delivery vehicle 22 2006
 
ALZA CORPORATION (13)
4,305,927 Method for the management of intraocular pressure 18 1980
4,874,388 Multi-layer delivery system 62 1987
4,865,845 Release rate adjustment of osmotic or diffusional delivery devices 97 1987
5,034,229 Dispenser for increasing feed conversion of hog 66 1988
5,112,614 Implantable delivery dispenser 89 1989
5,057,318 Delivery system for beneficial agent over a broad range of rates 110 1990
5,110,596 Delivery system comprising means for delivering agent to livestock 33 1990
5,059,423 Delivery system comprising biocompatible beneficial agent formulation 92 1990
5,137,727 Delivery device providing beneficial agent stability 104 1991
5,234,692 Delivery device with a protective sleeve 83 1992
5,234,693 Delivery device with a protective sleeve 82 1992
5,308,348 Delivery devices with pulsatile effect 68 1993
5,997,902 Ruminal drug delivery device 8 1998
 
C.R. BARD, INC. (2)
6,248,112 Implant delivery system 72 1998
6,447,522 Implant delivery system 80 2001
 
ADVANCED CARDIOVASCULAR SYSTEMS, INC. (1)
6,283,949 Refillable implantable drug delivery pump 182 1999
 
ASTRAZENECA AB (1)
6,670,368 Pyrimidine compounds with pharmaceutical activity 10 2001
 
DOW CORNING CORPORATION (1)
5,874,388 Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant 6 1997
 
GREATBATCH LTD. (1)
2005/0190,527 SPRING CONTACT SYSTEM FOR EMI FILTERED HERMETIC SEALS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES 2005
 
HOLLIS-EDEN PHARMACEUTICALS, INC. (1)
2003/0060,425 Immune modulation method using steroid compounds 23 2001
 
JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (1)
2002/0136,848 LACTONE-CONTAINING RESIN COMPOSITION, MOLDED OBJECT THEREOF, AND FILM 12 1999
 
KONINKLIJKE PTT NEDERLAND N.V. (1)
5,557,318 Method and apparatus for permitting a viewer to scan through a plurality of video signals provided by a transmitter 14 1995
 
MEDTRONIC, INC. (1)
5,976,109 Apparatus for drug infusion implanted within a living body 43 1996
 
MICROSOLUTIONS, INC. (1)
6,436,091 Methods and implantable devices and systems for long term delivery of a pharmaceutical agent 28 1999
 
NIPPON DENSAN CORPORATION (1)
5,336,057 Micropump with liquid-absorptive polymer gel actuator 23 1993
 
SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (1)
5,219,572 Controlled release delivery device for macromolecular proteins 28 1991
 
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (1)
5,279,608 Osmotic pumps 68 1991
 
UNIVERSITY OF IOWA RESEARCH FOUNDATION (1)
5,713,847 Human drug delivery device for tinnitus 66 1996
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
5,836,935 Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body 145 1997
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (5)
5,511,355 Construction element 30 1992
5,368,588 Parenteral fluid medication reservoir pump 77 1993
2003/0104,063 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers 18 2002
2003/0059,376 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same 13 2002
2003/0044,467 Gel composition and methods 14 2002

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
INTARCIA THERAPEUTICS, INC. (3)
8,299,025 Suspension formulations of insulinotropic peptides and uses thereof 0 2008
8,273,365 Two-piece, internal-channel osmotic delivery system flow modulator 1 2012
8,367,095 Two-piece, internal-channel osmotic delivery system flow modulator 0 2012
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
8,440,226 Solvent/polymer solutions as suspension vehicles 0 2012

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 14, 2015
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 14, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 14, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00